Zafirlukast for Chronic Asthma: Convenient and Generally Safe,But is it Effective?

Kelloway J.S. . Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma. Ann Pharmacother 1997; 31: 1012-21.

Product information. Zyflo Filmtab (zileuton tablets). North Chicago, IL: Abbott Laboratories, December 1996.

Professional information brochure. Accolate tablets (zafirlukast). Wilmington, DE: Zeneca Pharmaceuticals, 1996.

Taylor I.K. , O'Shaughnessy K.M. , Fuller R.W. , Dollery C.T. . Effect of cysteinyl-leukotriene-receptor antagonist ICI 204,219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 1991; 337: 690-4.

Finnetty J.P. , Wood-Baker R. , Thomson H. , Holgate S.T. . Role of cysteinyl-leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204,219 a potent leukotriene D₄ receptor antagonist. Am Rev Respir Dis 1992; 145: 746-9.

Hendeles L. , Harman E. . Use of allergen bronchoprovocation to screen drugs for anti-asthma activity. Pharmacotherapy 1997; 17(suppl): 39S-49S.

Israel R. , Rubin P. , Kemp J.P. , Grossman J. , Pierson W. , Siegel S.C. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann Intern Med 1993; 119: 1059-66.

Hui K.P. , Taylor I.K. , Taylor G.W. , Rubin P. , Kesterson J. , Barnes N.C. . Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. Thorax 1991; 46: 184-9.

Spector S.L. , Smith L.J. , Glass M. , Group I.A.T. . Effects of 6 weeks of therapy with oral doses of ICI 204, 219, a leukotriene D₄ receptor antagonist, in subjects with bronchial asthma: a randomized, double-blind, placebo controlled trial. Am J Respir Crit Care Med 1994; 150: 618-23.

Suissa S. , Dennis R. , Ernst P. , Sheehy O. , Wood-Dauphinee S. . Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. Ann Intern Med 1997; 126: 177-83.

National Asthma Education and Prevention Program. Expert Panel Report-II: guidelines for the diagnosis and management of asthma. US Department of Health and Human Services, National Institutes of Health, February 1997. (This document can be downloaded from the Internet: http://www.nhlbi.nih.gov/nhlbi/lung/asthma/prof/asthgdln.htm).

Svendsen U.G. , Frølund L. , Madsen F. , Nielsen N.H. , Holstein-Rathlou N.H. , Weeke B. . A comparison of the effects of sodium cromoglycate and beclomethasone dipropionate on pulmonary function and bronchial hyperreactivity in subjects with asthma. J Allergy Clin Immunol 1987; 80: 68-74.

Molema J. , van Herwaarden C.L. , Folgering H.T. . Effects of long-term treatment with inhaled cromoglycate and budesonide on bronchial hyperresponsiveness in patients with allergic asthma. Eur Respir J 1989; 2: 308-16.

Pedersen S. , Hansen O.R. . Budesonide treatment of moderate and severe asthma in children: a dose-response study. J Allergy Clin Immunol 1995; 95: 29-33.

Package insert. Flovent (fluticasone propionate). Research Triangle Park, NC: Glaxo-Wellcome Inc., March 1996.

Leff J.A. , Bronsky E.A. , Kemp J. , Pearlman D.S. , Hendeles L. , Busse W.W. Montelukast (MK-0476) inhibits exercise-induced bronchoconstriction (EIB) over 12 weeks without causing tolerance (abstract). Am J Respir Crit Care Med 1997; 155: A977.

Rosenthal R. , Lavins B.J. , Hanby L.A. . Effect of treatment with zafirlukast (Accolate) on bronchial hyperresponsiveness with mild to moderate asthma (abstract). J Allergy Clin Immunol 1996; 97: A250.

Aalbers R. , DeMonchy J.G.R. . Cysteinyl-leukotriene receptor antagonist, bronchoconstriction, and airway hyperreactivity (letter). Lancet 1991; 338: 445.

Van Essen-Zandvliet E.E. , Hughes M.D. , Waalkens H.J. , Duiverman B.J. , Pocock S.J. , Kerrebijn K.F. Effects of 22 months of treatment with inhaled corticosteroids and/or beta₂-agonists on lung function, airway responsiveness, and symptoms in children with asthma. Am Rev Respir Dis 1992; 146: 547-54.

Locke R.F. , Lavins B.J. , Snader L. . Effects of 13 weeks of treatment with ICI 204, 219 (Accolate) in patients with mild-to-moderate asthma (abstract). J Allergy Clin Immunol 1995; 95: 350.

Kelloway J.S. , Wyatt R.A. , Adlis S.A. . Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994; 154: 1349-53.